Oral Abstract Session:
272. Pediatric Viral Infections
Saturday, October 6, 2018: 2:00 PM-3:15 PM
Room: S 156

Tracks: Pediatric ID, Trainee


Moderators:  Sahera Dirajlal-Fargo, M.S, D.O., FAAP, Rainbow babies and Children's Hospital, Case Western School of Medicine and Yvonne Maldonado, MD, FIDSA, FPIDS, Stanford University School of Medicine

Presentations:
2:15 PM
High Incidence of Enterovirus, HHV6, Parechovirus and Adenovirus Blood Viremia in Children 0 to 3 Years Old Presenting with Fever Without Source
Arnaud G. L'Huillier, MD; Chiara Mardegan, MD; Samuel Cordey, PhD; Fanny Luterbacher, MD; Sebastien Papis, MD; Florence Hugon, RN; Laurent Kaiser, MD; Alain Gervaix, MD; Klara Posfay-Barbe, MD, MS; Annick Galetto-Lacour, MD
2:30 PM
HCV Screening Practices Among Adolescents and Young Adults in a National Sample of Federally Qualified Health Centers in the U.S.
Rachel L. Epstein, MD, MA; Jianing Wang, MSc; Kenneth Mayer, MD; Jon Puro, MPH/HA; C. Robert Horsburgh, MD MUS; Benjamin P. Linas, MD, MPH; Sabrina A. Assoumou, MD, MPH
2:45 PM
Higher Rates of Hospitalization and Infection-Related Hospitalization among HIV-Exposed Uninfected Infants Compared to HIV Unexposed Uninfected Infants in the US
Sarah M. Labuda, MD, MPH; Yanling Huo, MS; Deborah Kacanek, ScD; Kunjal Patel, DSc, MPH; Jennifer Jao, MD, MPH; Krista Huybrecthts, MS, PhD; Sonia Hernandez-Diaz, MD, DrPH; Ellen G. Chadwick, MD; Gwendolyn Scott, MD; Sandra Burchett, MD, MS; Christiana Smith, MD, MS; Fatima Kakkar, MD; Russell Van Dyke, MD, FIDSA
3:00 PM
Decreased T-cell Response, But Appropriate Antibody Production to Tetanus Vaccine Among HIV-Exposed Uninfected infants in Botswana
Christiana Smith, MD, MS; Natasha Moraka, BS; Maryanne Ibrahim, BS; Sikhulile Moyo, PhD; Gloria Mayondi, BS; Betsy Kammerer, PhD; Jean Leidner, MS; Simani Gaseitsiwe, PhD; Roger Shapiro, MD, MPH; Shahin Lockman, MD, MS; Adriana Weinberg, MD, FIDSA

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.